The usefulness and relevance of diabetes clinical guidelines are beyond doubt. Their use is widespread among internal medicine clinicians, though they have a weakness: “The most relevant information ...
Electronic health records used to bridge gap on benefits of SGLT-2 inhibitors for type 2 diabetesDiabetes drugs that may soon ...
The Food and Drug Administration recently approved Belgium-based Janssen Pharmaceuticals’ drug Invokamet XR for first-line use to improve glycemic control in diabetic adults when paired with diet and ...
A UC San Francisco analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new ...
A BMJ guideline put patient risk into the equation for assessing the suitability of SGLT-2 inhibitors and GLP-1 receptor agonist drugs for type 2 diabetes. Their use in type 2 diabetes was only ...
The medication change that could save 20,000 lives a year - The once-daily tablet ‘works very well’ in a wide range of ...
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.
Diabetes specialist nurse Anwen Jones provides an update on some key principles in management of diabetes in primary care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results